Portfolio & pipeline
The pipeline.
Devices and tools at every stage — born at the bedside, validated in simulation, and protected where protection matters.
Temple Laryngoscope
The soiled airway — blood, vomit, secretions — is where video laryngoscopy fails and patients die. The Temple Laryngoscope is an oxygenating video laryngoscope blade with an integrated high-velocity, lens-clearing oxygen jet: the camera stays clear, and the jet delivers oxygen where it’s needed most.
The device concept was published in Cureus (2026). A randomized, blinded simulation study — Temple Laryngoscope versus standard video laryngoscopy in a simulated hematemesis airway — is under review.
Read the concept paper →- Concept (complete)
- Simulation (complete)
- Prototype (complete)
- Evidence
- Regulatory
- Market
Vascular Access Exchange System
A sheath system that lets clinicians exchange catheters without losing access — reducing repeat punctures and the risks that come with them. Co-invented; U.S. provisional patent application filed 2022.
- Concept (complete)
- Design (complete)
- Provisional filed
- Prototype
- Evidence
Pediatric Delivery Design — Guise Medical
Founded and led design at Guise Medical LLC (2021–2023): pediatric products designed, simulated, and manufactured to reduce children’s anxiety during medication administration. Iterated through Fusion 360 CAD, Blender, and COMSOL multiphysics simulation — the same toolchain behind every Kathero device. Guise Medical has since concluded operations.
Read the published research →Audit-Oriented Randomization Tool
A transparent, open-source Python tool for randomized binary allocation in clinical trials — built for reproducibility and auditability, published in Cureus (2026). Trustworthy research infrastructure is a device, too.
Recognition
Design work placed 3rd nationally in the Society of Interventional Radiology Biodesign Competition (2022), after a national semifinal run in 2020.
Bring us the problem, not the polish.
The best devices start as a complaint from someone doing the work. If you have one — or want to build alongside us — talk to us.
Start a conversation →